Gallbladder cancer is a malignant neoplasm that arises from the epithelial cells of the gallbladder mucosa. This disease is highly aggressive and is often diagnosed at late stages, which significantly reduces the chances of successful treatment. In most cases, tumors of this type develop from adenocarcinomas, although there are also other morphological variants. The main factor contributing to the development of cancer is the presence of chronic inflammation of the gallbladder, but its development is also influenced by genetic, environmental and predisposing factors, including age-related changes and gender differences. Today, gallbladder cancer is one of the most complex and pressing problems of modern oncology, due to its low predictability and high degree of malignancy.
History of the disease and interesting historical facts
The history of gallbladder cancer can be traced back several centuries. The first documented cases of the disease are attributed to the works of famous anatomists and surgeons, such as Hippocrates and Galen. In the 18th-19th centuries, doctors began to systematically describe cases of cancer, including the gallbladder, but the mechanisms of its occurrence remained poorly understood until the mid-20th century. In the 1930-40s, scientists began to identify the connection between gallstones and the development of neoplasms, which was subsequently confirmed by numerous epidemiological studies. Thus, in the 1980s, the role of cartilaginous and cellular changes leading to malignant degeneration became known. Despite the development of diagnostic technologies, gallbladder cancer remains a rare diagnosis, occurring in 1-2% of all malignant diseases.
Epidemiology
According to statistics, gallbladder cancer ranks 5-7 among malignant tumors of the digestive system. In 2020, about 200,000 new cases were registered worldwide, and the mortality rate was about 150,000 people. The highest incidence is observed in Asia and South America, while in Europe and North America it is significantly lower. According to studies, the incidence among women is almost twice as high as among men, which is associated with hormonal factors and the spread of biliary tract diseases. It is important to note that gallbladder cancer is often diagnosed at late stages, which is associated with vague symptoms and low patient awareness of possible risks.
Genetic predisposition to this disease
Minor genetic changes can lead to malignant diseases, including gallbladder cancer. Among the genes involved is TP53, which is responsible for cell cycle control and DNA repair. This gene is often mutated in tumor cells, indicating its significant role in carcinogenesis. There are other genes, such as KRAS and CDKN2A, that may also be involved in the development of gallbladder cancer. However, more research is still needed to definitively identify all the genetic risk factors associated with this disease.
Risk factors for the development of this disease
There are several risk factors that contribute to the development of gallbladder cancer. The main ones include:
- Chronic inflammation of the gallbladder (cholecystitis)
- Presence of gallstones - high cholesterol and bilirubin levels
- Age – the risk increases after 50 years
- Gender – the disease is more common in women
- Genetic predisposition – presence of cases of the disease in the family history
- Smoking and alcohol
- Certain diseases such as diabetes and obesity
- Environmental factors – exposure to chemicals such as pesticides and aromatic hydrocarbons
These factors significantly increase the likelihood of developing cancer, and understanding them can help develop prevention methods.
Diagnosis of this disease
Diagnosis of gallbladder cancer involves many methods and depends on the stage of the disease. The main symptoms include:
- Pain in the right hypochondrium
- Nausea and vomiting
- Loss of appetite and weight
- Jaundice
- Change in color of stool and urine
Laboratory tests may include blood tests for tumor markers such as CA 19-9. Radiological diagnostic methods include ultrasound, CT, and MRI, which allow visualization of the gallbladder and surrounding structures. A biopsy of the tumor may be required to confirm the diagnosis. Differential diagnosis includes other diseases such as cholecystitis and gallbladder polyps, which requires a comprehensive approach to analyzing all available data.
Treatment
Treatment for gallbladder cancer depends on the stage of the disease and the patient's overall condition. The main approaches include:
- Surgical treatment – cholecystectomy (removal of the gallbladder) is the main method of treatment in the early stages.
- Pharmacological treatment – chemotherapy and targeted therapy may be used for new areas.
- Radiation therapy – used as an adjunct to surgery or in cases of inoperable tumors.
- Supportive therapy is the implementation of measures to maintain the general health of the patient, which highlights the importance of an integrated approach.
The success of treatment directly depends on early diagnosis and the correct choice of treatment.
List of medications used to treat this disease
Among the drugs used to treat gallbladder cancer are:
- Cisplatin
- Gemcitabine
- Fluorouracil
- Olaparib (targeted therapy)
- Erlotinib (targeted therapy)
The combination of these drugs can significantly increase the effectiveness of therapy, but is not suitable for all patients.
Disease monitoring
Disease monitoring is carried out at several stages:
- Regular tests and examinations to detect relapses
- Evaluation of liver function and biliary tract condition
- Psychological support and rehabilitation of the patient
- The prognosis for survival depends on the stage of the disease at the time of diagnosis and the success of treatment.
It is important to identify possible complications such as metastases in the liver and other organs, which requires constant monitoring.
Age-related features of the disease
Gallbladder cancer has different age-related manifestations. In young patients, the disease is less common and, as a rule, has a more favorable prognosis. At the same time, in older people, the disease is highly aggressive, which is explained by concomitant diseases and a weakened immune system. Statistically, most cases of gallbladder cancer are diagnosed in people over 60 years of age, which emphasizes the importance of periodic screening studies in this age group.
Questions and Answers
- What are the main symptoms of gallbladder cancer? The main symptoms include pain in the right hypochondrium, nausea, jaundice and changes in appetite.
- What is the chance of recovery with early diagnosis? Treatment success increases significantly with early detection of the disease and can be as high as 80% in some cases.
- What are the risk factors for developing this disease? Chronic inflammatory diseases, the presence of gallstones, smoking and genetic predisposition.
- How often should screening tests be performed? Screening is recommended every 6 to 12 months for people at high risk.
- What are the treatments for gallbladder cancer? The main methods include surgery, chemotherapy and radiation therapy.
Advice from Dr. Oleg Korzhikov
Dr. Oleg Korzhikov emphasizes the importance of early diagnosis and awareness of the symptoms of gallbladder cancer. “Do not ignore abdominal discomfort, especially if it is accompanied by other symptoms,” he says. “Regular physical examinations and tests will help identify the problem at an early stage. Maintaining a normal weight and a balanced diet are also important factors in preventing this disease.” Medical professionals should be attentive to each case, and at the slightest suspicion of a problem, refer patients for additional examinations.
